Lupiwighteone as an Antitumor Agent Reverses Multidrug Resistance in K562/ADR Cells by Regulating Cellular Prion Protein-Oct4 Axis.
Researchers studied Lupiwighteone (Lup) in drug-resistant leukemia cells. Lup reversed Multidrug Resistance (MDR) in K562 cells. Potential mechanism for cancer treatment. Important for overcoming chemotherapy resistance.
- Hu K et al (2024).
- Anticancer Agents Med Chem.
- PubMed:
- 39129165